Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data.

× No keyword cloud information.

27 in total

Review 1. Polymeric materials for theranostic applications.

Authors: Zhe Wang; Gang Niu; Xiaoyuan Chen
Journal: Pharm Res Date: 2013-06-14 Impact factor: 4.200

Review 2. Objective: tumor. Strategies of drug targeting at the tumor mass level.

Authors: C Martín Sabroso; A I Torres-Suárez
Journal: Clin Transl Oncol Date: 2013-07-12 Impact factor: 3.405

Review 3. Nanoparticles containing insoluble drug for cancer therapy.

Authors: Shutao Guo; Leaf Huang
Journal: Biotechnol Adv Date: 2013-10-08 Impact factor: 14.227

Review 4. Current Update of a Carboxymethylcellulose-PEG Conjugate Platform for Delivery of Insoluble Cytotoxic Agents to Tumors.

Authors: Yang Yang; Joseph Bteich; Shyh-Dar Li
Journal: AAPS J Date: 2016-11-21 Impact factor: 4.009

Review 5. The expanding role of prodrugs in contemporary drug design and development.

Authors: Jarkko Rautio; Nicholas A Meanwell; Li Di; Michael J Hageman
Journal: Nat Rev Drug Discov Date: 2018-04-27 Impact factor: 84.694

6. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts.

Authors: Xinghe Wang; Gang Zhao; Sang Van; Nan Jiang; Lei Yu; David Vera; Stephen B Howell
Journal: Cancer Chemother Pharmacol Date: 2009-07-11 Impact factor: 3.333

Poly-(L)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data.

Review 1. Polymeric materials for theranostic applications.

Review 2. Objective: tumor. Strategies of drug targeting at the tumor mass level.

Review 3. Nanoparticles containing insoluble drug for cancer therapy.

Review 4. Current Update of a Carboxymethylcellulose-PEG Conjugate Platform for Delivery of Insoluble Cytotoxic Agents to Tumors.

Review 5. The expanding role of prodrugs in contemporary drug design and development.

6. Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts.

7. Phase 2 trial of paclitaxel polyglumex with capecitabine for metastatic breast cancer.

Review 8. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.

9. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors.

10. Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane.